Home » Newsletters » BioWorld Science

BioWorld Science

June 18, 2019

View Archived Issues

LNC helps TNBC go AWOL

Gilead initiates phase I study of GS-1423 in advanced solid tumors

Inhibiting CCL24 with CM-101 reduces fibrosis and inflammation in systemic sclerosis

Luspatercept MOA: Up for grabs?

Increased clotting contributes to cardiovascular risk in HIV-infected individuals

Bayer, Deutsches Krebsforschungszentrum patent aryl hydrocarbon receptor antagonists

Collaborative Medicinal Development describes ferroptosis inhibitors

New PPAR agonists identified at Sichuan Kelun-Biotech Biopharmaceutical

Positive 6-month results from phase II open-label study of ATI-502 in androgenetic alopecia

Regeneron Pharmaceuticals initiates phase II study of REGN-5069 in osteoarthritis of the knee

Ribomic presents positive topline results from phase I/IIa SUSHI study of RBM-007 in wet AMD

Avelumab plus axitinib combination demonstrates antitumor activity in first-line HCC

Phase I results for venetoclax plus high-dose cytarabine in children with relapsed/refractory AML

New PRMT5 inhibitors presented by Jubilant Biosys

Kyoto Pharmaceutical Industries discovers albumin-binding prodrugs

CB-5064 analogues for weight and fat loss tested in vitro and in vivo

Netakimab safe and effective in spondyloarthritis: data from the phase III ASTERA trial

Repeat dosing of KZR-616 is well tolerated in patients with systemic lupus erythematosus

RNF213 gene variant found to cause pulmonary arterial hypertension with poor prognosis

Xeris reports promising data from phase III study of ready-to-use glucagon

FDA approves Victoza for type 2 diabetes in children and adolescents

BI-765063 begins first-in-human study in advanced solid tumors

CRV-431 decreases fibrosis and key biomarkers of liver disease in experimental model

PB-2452 reverses ticagrelor antiplatelet activity in older and elderly patients in phase IIa trial

European approval of Lynparza as first-line maintenance treatment for BRCAm advanced ovarian cancer

Rozlytrek approved in Japan for NTRK fusion-positive, advanced recurrent solid tumors

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...